Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 2 drugs with upcoming expirations
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Flovent — CUTIVATE
Application NDA019958 (NDA)
Flovent — CUTIVATE
Application NDA019957 (NDA)
Flovent — FLONASE
Application NDA020121 (NDA)
Flovent — FLOVENT
Application NDA020548 (NDA)
Flovent — FLOVENT
Application NDA020549 (NDA)
Flovent — FLOVENT DISKUS 100
Application NDA020833 (NDA)
Flovent — FLOVENT HFA
Application NDA021433 (NDA)
Flovent — CUTIVATE
Application NDA021152 (NDA)
Flovent — FLONASE ALLERGY RELIEF
Application NDA205434 (NDA)
Flovent — FLONASE SENSIMIST ALLERGY RELIEF
Application NDA022051 (NDA)
Flovent — XHANCE
Application NDA209022 (NDA)
Nuzyra — NUZYRA
Application NDA209816 (NDA)
Nuzyra — NUZYRA
Application NDA209817 (NDA)
Flovent — ARNUITY ELLIPTA
Application NDA205625 (NDA)
Flovent — ARMONAIR DIGIHALER
Application NDA208798 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)